Home
Ingredient Beauty Benefits

Route · Device-based

Laser hair removal: at 12 months, diode gave 69.2% and IPL 52.7% — **reduced, not removed**

In a left-to-right intrapatient trial of 30 people that counted hairs **12 months after the last treatment**, the diode laser achieved **69.2%** reduction and IPL **52.7%** (P < .01). The diode hurt more. Another trial reported **90–94%** reduction at 18 months. **That the numbers diverge this much between studies is itself the state of the evidence.**

Last checked Sep 17, 2026

Korean classification Being checkedThe regulatory class has not yet been confirmed against a primary document. It will be filled in once it is.

Laser hair removal works because melanin in the hair absorbs light, turns it into heat, and that heat damages the follicle. That the target is melanin determines almost everything about this procedure.

  • The darker the hair and the lighter the skin, the greater the contrast between target and background, and the better it works.
  • White, blond and grey hair have almost no melanin, so there is no target.
  • Darker skin absorbs the light too, which raises the risk of burns.

In Korea the common devices are diode (800–810 nm), alexandrite (755 nm) and IPL. IPL is not a laser but is used for the same purpose, and it is compared head-to-head below.

A note on terminology first. English-language literature usually calls this hair reduction, not removal. The figures below show why that word is the accurate one.

We have not opened the Korean device approval record, so the classification here says 'being verified'.

What is established

Moderate evidence

Diode 69.2%, IPL 52.7% — figures at 12 months

A 2013 intrapatient, left-to-right, assessor-blinded, controlled trial in Germany. Thirty participants with skin types II–III and unwanted axillary hair had IPL assigned to one side and an 800 nm diode laser to the other, six treatments each at four-week intervals.

Because it is the same person's two armpits, skin tone, hormones and hair calibre are matched automatically. This site rates that design highly.

Hairs were counted from close-up photographs 12 months after the last treatment. The primary endpoint was reduction in hair growth, analysed on an intention-to-treat basis.

The results (from baseline, at 3 and 12 months after the last treatment):

  • Diode laser: 59.7% → 69.2%
  • IPL: 42.4% → 52.7%
  • Both devices significantly reduced hair counts, and the diode was significantly better (P < .01).
  • Pain was significantly worse with the diode — 3.7 ± 2.1 against 1.6 ± 1.4 on a visual scale (P < .01).

The important part of this item is what remained. A year after finishing all six sessions, 30.8% of hairs were still there on the diode side and 47.3% on the IPL side.

And there is another reason this trial is unusual: it counted at 12 months. Most device pages on this site stop following up at three to six months. In hair removal, 'no hair right after the session' means nothing, so this design is essential.

  • Randomised controlled trial in people · 30 participants · 52 weeks · Compared with another active ingredient · Funding not declared · Endpoint clinical events (cancers, lesion counts) PMID 23278132
Moderate evidence

Another trial reported 90–94% at 18 months

The 2011 study is a prospective, single-centre, bilaterally paired, blinded, randomised split-leg design. Twenty-two patients received high-fluence single-pass diode on one leg and low-fluence multiple-pass diode on the other, with hair counts at 6 and 18 months after five treatment sessions.

Two findings.

  • Both techniques achieved 90–94% hair reduction, comparable to each other.
  • Hair counts at six months were comparable to those at 18 months. The authors read this as meaning six-month counts can be considered indicative of long-term results.
  • The low-fluence multiple-pass technique was significantly less painful.

The second line is practically useful, because it tells you when the result settles. Hair still present at six months largely stays.

The authors also wrote that the low-fluence multiple-pass approach achieves permanent hair removal with less discomfort and fewer adverse effects, especially in darker skin — a response to the structural problem that burn risk rises with skin tone.

But this is 22 people, on legs. A different site gives a different answer.

We have attached a long-term evaluation of an 800 nm diode with vacuum-assisted suction alongside; we could not confirm its detailed figures from the abstract.

  • Randomised controlled trial in people · 22 participants · 78 weeks · Compared with another active ingredient · Funding not declared · Endpoint clinical events (cancers, lesion counts) PMID 21197525
Not established

The gap between 69% and 94% is the state of the evidence

Put the numbers from the two items above side by side.

  • 2013 trial: 69.2% at 12 months (diode, axilla, six sessions)
  • 2011 trial: 90–94% at 18 months (diode, legs, five sessions)

Same class of laser, 25 percentage points apart.

There are plenty of candidate reasons — the site (axilla against leg), hair calibre and growth cycle, participants' skin types, device settings, how hairs were counted, and sample size (30 and 22).

We cannot say which is right. Neither trial is badly designed, and they have never been compared directly.

What the gap means is this: 'laser hair removal reduces hair by X%' cannot be said without conditions. Which area, what hair, which device, how many sessions — these move the result a great deal.

Three things, though, did not change in any trial.

  • The hair did not disappear. Even the best result left 6–10%.
  • It takes several sessions. The trials above used five or six.
  • White and blond hair are not targets for this procedure. With no melanin, there is nowhere for the light to be absorbed.

Known risks

  • Pain during treatment. Above, the diode hurt significantly more than IPL, and high fluence more than low fluence.
  • Transient erythema and perifollicular oedema.
  • Burns and blistering. Skin melanin absorbs the light too, so risk is high in darker or recently tanned skin.
  • Hyperpigmentation and hypopigmentation.
  • Rarely, paradoxical hypertrichosis — hair increasing around the treated area — is reported.
  • Eye protection is mandatory.
  • Photosensitising medication should be disclosed beforehand.
  • Any adverse reaction is something to have seen by the clinic that performed the procedure.

What is not established

  • Reduction rates range from 52% to 94% across studies. What accounts for that spread has not been settled.
  • We did not identify a trial on this page comparing against no treatment.
  • Follow-up beyond 18 months is scarce.
  • Efficacy on white, blond and grey hair. This is structural: the target is melanin.
  • Which of diode, alexandrite and Nd:YAG suits which skin type.
  • We have not verified the Korean device approval class.

Whether to have it done is a decision to make with a doctor.

What this article relies on

  1. PubMed — 미국 국립의학도서관 문헌 데이터베이스National Library of Medicine · Checked on 2026-09-16